EUVIMEDEUVIMED entdecken
Open Access

Lactate dehydrogenase A–mediated CREB1 lactylation promotes breast cancer brain metastasis by transcriptionally activating cytoskeletal remodeling

Siqi Liu iD, Zhirui Bai iD, Yifan Qiao, Yihan Ge iD, Fengyi Qu, Meihan Li, Jizhao Wang, Xiaobo Shi, Yuan Ma, Jing Li iD, Xuhuan Cao, Feng Guo und 2 weitere

Neuro-Oncology · 2026

DOI: 10.1093/neuonc/noag114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Siqi Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China (S.L., Y.Q., Y.G., F.Q., M.L., X.S., Y.M.,…. Hauptthemen laut MEDLINE: Brain Neoplasms, Breast Neoplasms, Cyclic AMP Response Element-Binding Protein, Cytoskeleton. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain metastasis (BM) is a leading cause of mortality in breast cancer patients. This study utilizes single-cell RNA sequencing (scRNA-seq) to identify high-risk malignant subclusters and uncover potential therapeutic targets driving BM.

Methods

Five pairs of scRNA-seq data of primary breast tumors (PT) and BM were retrieved from the Gene Expression Omnibus (GEO) database. Following unsupervised clustering and cell-type annotation, specialized bioinformatic pipelines—including inferCNV and pseudotime trajectory analysis—were implemented to delineate malignant subpopulations and evolutionary states associated with high brain metastatic potential. Molecular mechanisms were investigated using ChIP-qPCR, nascent RNA labeling assay, and dual-luciferase assays. Clinical significance was evaluated in a 124 paired-patient cohort using propensity score matching (PSM), while in vivo metastatic potential was assessed via a murine carotid artery injection model.

Results

We identified a specific malignant epithelial subcluster (cluster 3) characterized by high lactate levels and superior BM potential and subsequently established CREB1 lactylation as a biomarker of this cluster. Mechanistically, lactate dehydrogenase A (LDHA)-mediated lactylation of CREB1 at lysine 136 (K136) enhances its transcriptional activity, upregulating cytoskeletal genes including CALML5, CNN2, and PDLIM1. This axis facilitates pseudopodia formation, cellular migration. In vivo, LDHA knockdown significantly reduced intracranial tumor burden. Clinically, high lactylation scores and high CALML5 expression are independent predictors of BM and overall survival.

Conclusions

The LDHA-lactylation-CREB1-cytoskeleton axis is a novel driver of BM, serving as a promising therapeutic target and prognostic biomarker for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsBreast NeoplasmsCyclic AMP Response Element-Binding ProteinCytoskeletonLactate Dehydrogenase 5Biomarkers, TumorHumansFemaleAnimalsMiceGene Expression Regulation, NeoplasticPrognosisTumor Cells, Cultured

Stichwörter der Autor:innen

brain metastasisbreast cancercytoskeletal remodelinglactylationscRNA-seq

Substanzen

Cyclic AMP Response Element-Binding ProteinCREB1 protein, humanLactate Dehydrogenase 5Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiation Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China (S.L., Y.Q., Y.G., F.Q., M.L., X.S., Y.M., J.L., X.C., X.Z., Y.S.).
  • School of Computer Science and Engineering, Xi'an University of Technology, Xi'an, China (Z.B.).
  • Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Oncology, Shangluo Central Hospital, Shangluo, China.

ORCID-Profile: Siqi Liu, Zhirui Bai, Yihan Ge, Jing Li, Yuchen Sun

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, S., Bai, Z., Qiao, Y., Ge, Y., Qu, F., Li, M., Wang, J., Shi, X., Ma, Y., Li, J., Cao, X., Guo, F., Zhang, X., & Sun, Y. (2026). Lactate dehydrogenase A–mediated CREB1 lactylation promotes breast cancer brain metastasis by transcriptionally activating cytoskeletal remodeling. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag114

Vancouver

Liu S, Bai Z, Qiao Y, Ge Y, Qu F, Li M, et al. Lactate dehydrogenase A–mediated CREB1 lactylation promotes breast cancer brain metastasis by transcriptionally activating cytoskeletal remodeling. Neuro-Oncology. 2026. doi:10.1093/neuonc/noag114

BibTeX
@article{Liu2026,
  author = {Liu, Siqi and Bai, Zhirui and Qiao, Yifan and Ge, Yihan and Qu, Fengyi and Li, Meihan and Wang, Jizhao and Shi, Xiaobo and Ma, Yuan and Li, Jing and Cao, Xuhuan and Guo, Feng and Zhang, Xiaozhi and Sun, Yuchen},
  title = {Lactate dehydrogenase A–mediated CREB1 lactylation promotes breast cancer brain metastasis by transcriptionally activating cytoskeletal remodeling},
  journal = {Neuro-Oncology},
  year = {2026},
  doi = {10.1093/neuonc/noag114}
}
Kostenlos starten →